Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Dow
QuintilesIMS
McKinsey
Farmers Insurance
Queensland Health
US Department of Justice
Argus Health
Boehringer Ingelheim

Generated: April 26, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin detemir recombinant

« Back to Dashboard

insulin detemir recombinant

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novo Nordisk Inc LEVEMIR insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 NDA Novo Nordisk N 0169-3687-12
Novo Nordisk Inc LEVEMIR insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 NDA Novo Nordisk N 0169-6438-10
Novo Nordisk Inc LEVEMIR insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 NDA Novo Nordisk N 0169-6438-98
Novo Nordisk Inc LEVEMIR insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 NDA A-S Medication Solutions N 50090-1276-0
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Express Scripts
Teva
Healthtrust
Medtronic
McKinsey
Accenture
US Department of Justice